Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| 10% | Westlake BioPartners Opportunity Fund I, L.P. | 869.3K | $6.96M | - |
| Dir | SEIDENBERG BETH C | 869.3K | $6.96M | - |
| CFO | GRASSO MARC | 450.0K | $3.60M | - |
| CEO | Biddle Warner Weston | 332.5K | $2.66M | - |
| Dir | CLARK IAN T | 65.4K | $523.5K | - |
Transactions
6 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2025-12-18 | Westlake BioPartners Opportunity Fund I, L.P. | 10% Owner | Buy | 133,333 | $7.50 | $999,997.50 | +18.1% | → |
| 2025-12-18 | SEIDENBERG BETH C | Director | Buy | 133,333 | $7.50 | $999,997.50 | +18.1% | → |
| 2025-12-15 | Walker Karen Marie | Chief Technology Officer | Sale+OE | 23,998 | $12.20 | $292,775.60 | -51.5% | → |
| 2024-02-12 | Vida Ventures, LLC | 10% Owner | Buy | 253,136 | $22.00 | $5,568,992.00 | New | → |
| 2024-02-12 | Northpond Ventures III GP, LLC | Former 10% Owner | Buy | 450,000 | $22.00 | $9,900,000.00 | New | → |
| 2024-02-12 | Bain Capital Life Sciences Investors, LLC | 10% Owner | Buy | 450,000 | $22.00 | $9,900,000.00 | +16.6% | → |